Medicare managed care Rx benefits may improve despite reimbursement cuts, APhA's Schulke suggests.
Executive Summary
MEDICARE HMO PAYMENT CUTS COULD INDIRECTLY IMPROVE Rx BENEFITS, APhA EXEC David Schulke suggested during a University of South Carolina pharmacy public policy seminar in Hilton Head, S.C. Feb. 9. Managed care companies have suggested that reimbursement cuts under the 1997 Balanced Budget Act could put drug benefits (offered by some plans as an inducement to seniors) in jeopardy. Schulke acknowledged that the changes will probably "put pressure on drug benefits," but maintained that the drug benefit is "such a powerful draw to get people to enroll in your plan, you wonder whether [eliminating drug benefits] will work."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth